BioFLECT™ In Vivo Preclinical Imager
18 Oct 2009
Watch this video to see the results that can be obtained using the BioFLECT™ In Vivo Preclinical Imager from Bioscan
About the company
Bioscan Inc.
Bioscan is a leading developer of advanced instrumentation for the detection, synthesis, and imaging of Radiolabeled Compounds used in four areas…
• Life Science Research
• Molecular Imaging
• Pharmaceutical Development
• Nuclear Medicine
Bioscan is a leading provider of SPECT (Single Photon Emission Computed Tomography) and PET (Positron Emission Tomography) imaging systems for preclinical applications. Our tools enable researchers, pharmaceutical and biotech organizations to improve their drug development research using in vivo animal models.
Our patented technology improves screening of drug pipeline candidates over classic in vitro methods by providing more relevant biological data, more consistency, as well as reduced cost and complexity. The unique imaging acuity of our products also makes it possible to translate research results from mouse models of human diseases to human clinical trials – driving increased speed to market for drugs.
Bioscan is also a supplier of innovative instruments for radioisotope detection and analysis in life science, pharmaceutical and nuclear medicine research applications. As an expansion of its involvement in nuclear medicine, Bioscan now provides a variety of automated synthesis modules for the production of PET (F-18 & C-11) radiopharmaceuticals. Our analytical instruments provide solutions to both chemical purity and quality control in many applications involving radio-TLC, radio-HPLC, and isotope detection.
Related products
Request Quote for All Products
Bioscan BioFLECT™ 400
Bioscan Inc.The new Bioscan BioFLECT 400 is the first in vivo optical imaging system offering true 360° fluorescence tomography. BioFLECT uses the photon emission data acquired from 360° and a state-of-the-art 3D reconstruction engine to quantitatively reconstruct the 3D spatial distribution of fluorescent probes in live animals. This approach yields superior, consistent resolution, sensitivity and quantitation throughout the subject. The impact for researchers is breakthrough optical imaging performance that can yield truly differentiated research results. BioFLECT 400 comes equipped with 4 standard laser and emission filter combinations. Researchers can select up to 8 additional lasers (for a maximum of 12), and up to 12 additional emission filters (for a maximum of 16), to image their preferred probes. Whether you image below 500 nm, above 700 nm, or somewhere in between, BioFLECT 400 can achieve your research objectives. BioFLECT 400 also supports emerging probes in the near-infrared spectrum with available lasers well into the 800 nm range for improved attenuation characteristics and even a 980 nm laser for use with up-converting fluorophores. Available filters can enable detection of emissions approaching 900 nm.